Status
Conditions
Treatments
About
The study is a global safety surveillance study of pregnancy outcomes in women who were exposed to ipilimumab during pregnancy and pediatric outcomes up to 5 years of age
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Other protocol defined inclusion/exclusion criteria could apply
0 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal